NASDAQ: CODX - Co-Diagnostics, Inc.

Lønnsomhet i seks måneder: -40.65%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Co-Diagnostics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Co-Diagnostics, Inc.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

flere detaljer
It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2017-07-12
ISIN US1897631057
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.codiagnostics.com
Цена ао 1.12
Prisendring per dag: -3.74% (0.7584)
Prisendring per uke: 0% (0.73)
Prisendring per måned: -22.03% (0.9363)
Prisendring over 3 måneder: -40.65% (1.23)
Prisendring over seks måneder: -40.65% (1.23)
Prisendring per år: -45.11% (1.33)
Prisendring over 3 år: -91.51% (8.6)
Prisendring over 5 år: -21.05% (0.9246)
Prisendring over 10 år: 0% (0.73)
Prisendring siden begynnelsen av året: -22.03% (0.9363)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 34.04 1
P/BV 0.3924 10
P/E 0 0
EV/EBITDA -0.4614 0
Total: 4.75

Effektivitet

Navn Betydning Karakter
ROA, % -34.09 0
ROE, % -41.08 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0632 10
Total: 9.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 3068.39 10
Lønnsomhet Ebitda, % 591.26 10
Lønnsomhet EPS, % 232.41 10
Total: 10
Flere detaljer

Institusjoner Volum Dele, %
Vanguard Group Inc 1781283 5.7
Renaissance Technologies, LLC 617000 1.97
Blackrock Inc. 501830 1.61
Geode Capital Management, LLC 294422 0.94
Bridgeway Capital Management, Inc. 272900 0.87
Bank Of New York Mellon Corporation 145621 0.47
Kestra Advisory Services, LLC 138607 0.44
Susquehanna International Group, LLP 107699 0.34
State Street Corporation 100647 0.32
Citadel Advisors Llc 96647 0.31

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.00999 17.09 1.54048



Veileder Stillingstittel Betaling Fødselsår
Mr. Dwight H. Egan Chairman & CEO 415.75k 1953 (72 år)
Mr. Brian L. Brown CPA CFO & Company Secretary 338.92k 1976 (49 år)
Dr. Brent C. Satterfield Ph.D. Co-Founder & Member of Scientific Advisory Board 237.5k 1977 (48 år)
Mr. Dan Bohrer CPA Vice President of Finance & Accounting N/A
Mr. Andrew Benson Head of Investor Relations N/A
Dr. Mayuranki Almaula Senior Vice President of Overseas Operations & Strategic Alliances N/A
Mr. Richard David Abbott President N/A 1972 (53 år)
Mr. David Nielsen Chief Operating Officer N/A
Mr. Christopher Thurston Chief Technology Officer N/A
Mr. Cameron Gundry Head of Commercialization LATAM/EUR

Adresse: United States, Salt Lake City. UT, 2401 South Foothill Drive - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.codiagnostics.com